Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
c-peptide (1 trial)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetic Neuropathies (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Polyneuropathies (Phase 2)
Trials (1 total)
Trial APIs (1 total)